Aquestive Therapeutics Inc
NASDAQ:AQST
Aquestive Therapeutics Inc
Other
Aquestive Therapeutics Inc
Other Peer Comparison
Competitive Other Analysis
Latest Figures & CAGR of Competitors
Company | Other | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
A
|
Aquestive Therapeutics Inc
NASDAQ:AQST
|
Other
$8.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Johnson & Johnson
NYSE:JNJ
|
Other
-$1B
|
CAGR 3-Years
-237%
|
CAGR 5-Years
-30%
|
CAGR 10-Years
N/A
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Other
$22m
|
CAGR 3-Years
-68%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
3%
|
|
Pfizer Inc
NYSE:PFE
|
Other
-$582m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
Merck & Co Inc
NYSE:MRK
|
Other
-$325m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-19%
|
|
Eli Lilly and Co
NYSE:LLY
|
Other
-$443.8m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-52%
|
See Also
What is Aquestive Therapeutics Inc's Other?
Other
8.3m
USD
Based on the financial report for Mar 31, 2024, Aquestive Therapeutics Inc's Other amounts to 8.3m USD.